Literature DB >> 11988167

Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims.

Ilona Gurevich1, Hadassah Tamir, Victoria Arango, Andrew J Dwork, J John Mann, Claudia Schmauss.   

Abstract

Five adenosines within the coding sequence of the serotonin 2C receptor (5-HT2C) pre-mRNA are converted to inosines by RNA editing (named A, B, C' (E), C, and D sites). In human prefrontal cortex (PFC), the most abundant 5-HT2C mRNA sequences result from editing at the A site, or from the editing combinations AC'C, ABCD, and ABD. In suicide victims with a history of major depression, C' site editing is significantly increased, D site editing is significantly decreased, and the C site shows a trend toward increased editing. Treatment of mice with the antidepressant drug fluoxetine (Prozac) causes changes in C', C, and D site editing that are exactly opposite to those seen in suicide victims. Thus, one outcome of fluoxetine treatment may be to reverse the abnormalities in 5-HT2C pre-mRNA editing seen in depressed suicide victims.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988167     DOI: 10.1016/s0896-6273(02)00660-8

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  139 in total

1.  Age-related gene-specific changes of A-to-I mRNA editing in the human brain.

Authors:  A Nicholas; J P de Magalhaes; Y Kraytsberg; E K Richfield; E Y Levanon; K Khrapko
Journal:  Mech Ageing Dev       Date:  2010-06-09       Impact factor: 5.432

2.  Serotonin 2c receptor RNA editing in major depression and suicide.

Authors:  Rebecca Lyddon; Andrew J Dwork; Mehdi Keddache; Larry J Siever; Stella Dracheva
Journal:  World J Biol Psychiatry       Date:  2012-03-09       Impact factor: 4.132

3.  A transition state analogue for an RNA-editing reaction.

Authors:  Brittany L Haudenschild; Olena Maydanovych; Eduardo A Véliz; Mark R Macbeth; Brenda L Bass; Peter A Beal
Journal:  J Am Chem Soc       Date:  2004-09-15       Impact factor: 15.419

4.  Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene.

Authors:  Rachel Flomen; Joanne Knight; Pak Sham; Robert Kerwin; Andrew Makoff
Journal:  Nucleic Acids Res       Date:  2004-04-15       Impact factor: 16.971

Review 5.  Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology.

Authors:  C B Brink; B H Harvey; J Bodenstein; D P Venter; D W Oliver
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

Review 6.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

7.  Development of the 5-HT2CR-Tango System Combined with an EGFP Reporter Gene.

Authors:  Yoshihisa Watanabe; Atsushi Tsujimura; Miku Aoki; Katsutoshi Taguchi; Masaki Tanaka
Journal:  J Mol Neurosci       Date:  2015-09-15       Impact factor: 3.444

8.  Genetic Architectures of Quantitative Variation in RNA Editing Pathways.

Authors:  Tongjun Gu; Daniel M Gatti; Anuj Srivastava; Elizabeth M Snyder; Narayanan Raghupathy; Petr Simecek; Karen L Svenson; Ivan Dotu; Jeffrey H Chuang; Mark P Keller; Alan D Attie; Robert E Braun; Gary A Churchill
Journal:  Genetics       Date:  2015-11-27       Impact factor: 4.562

9.  RNA editing of the IQ domain in Ca(v)1.3 channels modulates their Ca²⁺-dependent inactivation.

Authors:  Hua Huang; Bao Zhen Tan; Yiru Shen; Jin Tao; Fengli Jiang; Ying Ying Sung; Choon Keow Ng; Manfred Raida; Georg Köhr; Miyoko Higuchi; Hadi Fatemi-Shariatpanahi; Bradley Harden; David T Yue; Tuck Wah Soong
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

Review 10.  A-to-I RNA editing and human disease.

Authors:  Stefan Maas; Yukio Kawahara; Kristen M Tamburro; Kazuko Nishikura
Journal:  RNA Biol       Date:  2006-01-12       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.